Can you stay on Mounjaro 2.5mg for 8 weeks — and should you?

The real question: why you're considering staying put

If you're reading this, you're probably weighing up nausea or discomfort against impatience to see results, or you've heard conflicting things about how long you're supposed to stay at the starting dose. That uncertainty is completely understandable. The titration schedule exists precisely because tirzepatide affects people differently, and the 2.5mg phase protects you from front-loading too much, too soon.

Mounjaro's licensed schedule, as set out in the Mounjaro Summary of Product Characteristics on the eMC, is four weeks at each dose before increasing. So four weeks at 2.5mg, then four weeks at 5mg, and so on. Eight weeks at 2.5mg sits outside that standard path. It's not forbidden (prescribers can and do adjust pace) but it needs a reason, and that reason should come from a clinical conversation, not self-management.

The starter dose's main job is adjustment. Slowing gastric emptying and shifting your appetite set-point are powerful effects; 2.5mg gives your gut time to adapt before higher concentrations build. If those effects are still causing significant nausea at week four, the case for staying put a little longer becomes real, and our guide on whether you can stay on 2.5mg Mounjaro walks through that decision in more detail. If side effects have settled and weight is moving, prolonging the starter phase delays progress without obvious benefit.

When extending 2.5mg to eight weeks might make clinical sense

There are genuine situations where a prescriber might agree to hold at 2.5mg past the standard four weeks. Persistent nausea, vomiting or significant GI discomfort that hasn't settled are the clearest examples. Pushing through a dose increase in that context often makes symptoms worse rather than better, and a brief pause can mean the difference between continuing treatment long-term and stopping early.

The NHS guidance on weight management injections emphasises that dose titration should balance tolerability against effectiveness, the pace is not one-size-fits-all. A prescriber looking at your full picture (how bad the side effects are, how long they've lasted, your other health conditions) is the right person to make that call.

What a prescriber will not do is extend the starter dose indefinitely or without review. Eight weeks at 2.5mg is roughly the outer limit that might occasionally be clinically justified; staying there for months without moving up is unlikely to serve your health goals and falls outside the licensed approach.

If you're on 5mg and wondering about holding there, the considerations differ slightly, the guide to 5mg covers that in more detail.

What 2.5mg actually does (and doesn't do) for weight loss

People sometimes expect the starter dose to deliver visible results. The honest answer is that 2.5mg does have some effect on appetite and gastric emptying, but if you're wondering whether you can stay on 2.5mg Mounjaro specifically for weight loss, the clinical trial data that informs what's achievable with tirzepatide was generated at maintenance doses, not at 2.5mg. SURMOUNT-1, which involved 2,539 adults over 72 weeks and produced average weight reductions of around 20–21% at 15mg, was not measuring what eight weeks at a starter dose achieves.

Some early movement on the scales at 2.5mg is possible (appetite suppression begins to some degree from the first doses) but framing the starter as a weight-loss phase sets expectations that it was never designed to meet. The therapeutic work begins as you climb the schedule. That context matters when you're deciding whether another four weeks at 2.5mg is worth it versus addressing whatever is making you reluctant to move up.

For a fuller overview of how tirzepatide works and what the evidence says across the full dose range, the Mounjaro information page is a good starting point. The NHS medicines page for tirzepatide also covers expected effects and what to report to your prescriber.

How to handle this with your prescriber, practically

If you want to stay at 2.5mg past four weeks, say so explicitly at your next clinical review. Describe the symptoms clearly: when they're worst, how long they last, whether food or hydration is affected. That gives your prescriber something concrete to work with.

At nume, every repeat order goes through a clinical review, a named prescriber reads your update before anything is approved or dispensed. That's the right moment to raise titration concerns. If you haven't yet spoken to a prescriber and are wondering whether Mounjaro is right for you, starting a free consultation is the first step.

A few practical points worth raising in that conversation: whether your symptoms are improving week-on-week, whether you've tried the dose on a different day of the week, and whether dietary adjustments (smaller portions, lower fat meals around injection day) have made a difference. These details genuinely affect the titration decision. You can also read the FAQs on staying at a dose longer or browse the overview of weight-loss treatment options if you're still weighing things up.

One more thing: the question of whether you can permanently stay at the starter dose (not just for eight weeks but indefinitely) is addressed separately, including a specific look at whether staying on 7.5mg Mounjaro long-term is an option for those who have already climbed the schedule. The guide on staying at 2.5mg long-term covers that in detail.